Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. (CRL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRL · as of Jun 8, 2026
Key Statistics
Explore Charles River Laboratories International, Inc. Data
crl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 37 · Buy rate: 70.3%
The CRL analyst consensus is Buy, based on ratings from 37 Wall Street analysts over the past 3 months. The average 12-month price target is $213.17, representing +17.55% upside from the current price of $181.34.
Competitors & Peers
crl competitorsCRL
AVTR
BAX
BIO
CAI
DVAStock Performance
Full HistoryAbout Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Euro…
what is charles river laboratories international, inc. · crl stock overview · charles river laboratories international, inc. company profile · who is charles river laboratories international, inc. ceo · crl NYSE · charles river laboratories international, inc. headquarters · charles river laboratories international, inc. business segments
About Stock Overview & Key Data
Charles River Laboratories International, Inc. (CRL) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Jun 23, 2000. As of the latest trading session, CRL stock price is $181.34, with a market capitalization of $8.7B. The stock has returned +22.98% over the past 12 months and -9.09% year-to-date.
According to 37 Wall Street analysts, the consensus rating for Charles River Laboratories International, Inc. stock is Buy, with an average 12-month price target of $213.17. In fiscal year 2025, Charles River Laboratories International, Inc. reported revenue of $4.0B and net income of -$144.3M. For detailed data — including Charles River Laboratories International, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Charles River Laboratories International, Inc. (CRL) stock price is $181.34. The stock is traded on NYSE under the ticker symbol CRL. The 52-week range is $140.78 – $228.88.